ArticleHematology (Amsterdam, Netherlands)2016

Fasudil, a clinically safe ROCK inhibitor, decreases disease burden in a Cbl/Cbl-b deficiency-driven murine model of myeloproliferative disorders.

Basem M William et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.